# NeuroBionics: Research, Somerville, United States

> NeuroBionics: NeuroBionics is a biotechnology startup based in Boston, founded in 2023. Based in Somerville, United States. Founded 2023.

Source: https://millionrounds.com/startup/neurobionics (Millionrounds; every figure on the page links to its filing or article)

United States · [Research startup](https://millionrounds.com/companies)

# NeuroBionics

NeuroBionics is a biotechnology startup based in Boston, founded in 2023.

Email

Funding reported Last round: Non equity assistance

Research Somerville, United States

Follow NeuroBionics and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fstartup%2Fneurobionics)

Company summary

- **Founded:** 2023 3 years old
- **Team:** 16 11 to 50 people
- **Funding reported:** $4.2M in dollars
- **Last round:** Non equity assistance May 2024

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for NeuroBionics has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About NeuroBionics

NeuroBionics is a biotechnology startup based in Boston, founded in 2023.

The company focuses on precision bioelectronic medicine by developing minimally-invasive, implantable neural interface devices. These devices are designed to integrate seamlessly with the human body, advancing human health through innovative neuromodulation therapies. The core technology, known as evStim, features hair-thin, flexible bioelectronic fibers that support electrical, optical, and chemical recording and stimulation. This technology allows for precise therapeutic interventions in deep brain regions without the need for open surgery, using an endovascular approach to navigate through blood vessels. NeuroBionics aims to treat conditions such as Parkinson’s disease, epilepsy, and depression, as well as peripheral nervous system disorders. With approximately 10 employees, NeuroBionics has raised $5.08 million in funding, led by Dolby Family Ventures. The company is committed to making neuromodulation therapies more accessible and less invasive, ultimately benefiting millions of patients facing neurological challenges.

## What company datasets say NeuroBionics raised

Funding, as reported

Reported in all **$4.2M** in dollars

Rounds **1**

Last round **Non equity assistance**

Last round size **$5.0M**

Last round date **May 2024**

Investors listed **1**

SEC Form D **$4.2M sold, 1 filing, last Dec 2025**

## Founders and team

From NeuroBionics's own website: 3 on the team.

- **Ross Tsukashima** Head of Innovation
- **Bennett Lauture** R&D Engineer Intern
- **Karina Lamoreux** Quality Engineer Intern

## On 6 portfolio pages

Investors who name them

- [Dolby Family Ventures](https://millionrounds.com/fund/dolby-family-ventures)
- [Vanedge Capital](https://millionrounds.com/fund/vanedge-capital)
- [Future Ventures](https://millionrounds.com/fund/future-ventures)
- [GreyMatter Capital](https://millionrounds.com/fund/greymatter)
- [Device of Tomorrow Capital](https://millionrounds.com/fund/device-of-tomorrow-capital)
- [Jumpspace Ventures](https://millionrounds.com/fund/jumpspace-ventures)

Each firm lists NeuroBionics on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

health care biotechnology research mri-compatible devices manufacturing fiber optic neural stimulation minimally invasive neuromodulation neural interface technology wireless brain interfaces neural interfaces endovascular delivery endovascular deep brain stimulation biocompatible materials hospital & health care bioelectronic fibers chemical sensing neuroscience research tools

Built with from their website

Contact Form 7 Google Tag Manager LiteSpeed WordPress.org Spectro Hostinger CDN Font Awesome Google Workspace Viewport Meta Site Kit

+8 more

WPMU DEV Smush Cascade CMS Google Meet Act! Priority Hints Google Font API Microsoft Exchange FitVids.JS

- **Sector:** Research
- **Industry code:** NAICS 33911, 334510, SIC 3845
- **Region:** Massachusetts
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/neurobionics-38ad227cf2)

## Research in United States

Startups like it

- [**OpenAI** San Francisco · founded 2011 *Raised*](https://millionrounds.com/company/openai)
- [**Retro Biosciences** Redwood City · founded 2021 *Raised*](https://millionrounds.com/company/retro-biosciences)
- [**NewLimit** South San Francisco · founded 2022 *Raised*](https://millionrounds.com/company/newlimit)
- [**Pathos** New York · founded 2022 *Raised*](https://millionrounds.com/company/pathos)
- [**Colossal Biosciences** Dallas · founded 2021 *Raised*](https://millionrounds.com/company/colossal-biosciences)
- [**Oratomic** South Pasadena *Raised*](https://millionrounds.com/company/oratomic)
- [**Beeline Medicines** Stamford · founded 2025 *Raised*](https://millionrounds.com/company/beeline-medicines)
- [**Element Biosciences** San Diego · founded 2017 *Raised*](https://millionrounds.com/company/element-biosciences)

## Is this your company?

Add your raise, your deck and your story, and put NeuroBionics in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)